{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:58:27Z","timestamp":1793663907203,"version":"4.5.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS094438"],"award-info":[{"award-number":["NS094438"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS094438"],"award-info":[{"award-number":["NS094438"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["HT9425-24-1-0180"],"award-info":[{"award-number":["HT9425-24-1-0180"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s43440-025-00720-x","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T06:01:22Z","timestamp":1743228082000},"page":"809-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Blockade of IgG Fc receptors reduces pain after intervertebral disc injury"],"prefix":"10.1007","volume":"77","author":[{"given":"Xiaoyou","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Sahbaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Zhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ming","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade S.","family":"Kingery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"720_CR1","doi-asserted-by":"crossref","unstructured":"Lucas JW, Connor EM, Bose J, Back. Lower limb, and upper limb pain among U.S. Adults, 2019. NCHS Data Brief. 2021(415):1\u20138.","DOI":"10.15620\/cdc:107894"},{"issue":"6","key":"720_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.21037\/atm.2020.02.175","volume":"8","author":"A Wu","year":"2020","unstructured":"Wu A, March L, Zheng X, Huang J, Wang X, Zhao J, et al. Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the global burden of disease study 2017. Ann Transl Med. 2020;8(6):299.","journal-title":"Ann Transl Med"},{"issue":"6","key":"720_CR3","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/S2665-9913(23)00133-9","volume":"5","author":"R The Lancet","year":"2023","unstructured":"The Lancet R. The global epidemic of low back pain. Lancet Rheumatol. 2023;5(6):e305.","journal-title":"Lancet Rheumatol"},{"key":"720_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-med-011817-044739","volume":"69","author":"N Volkow","year":"2018","unstructured":"Volkow N, Benveniste H, McLellan AT. Use and misuse of opioids in chronic pain. Annu Rev Med. 2018;69:451\u201365.","journal-title":"Annu Rev Med"},{"issue":"6","key":"720_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/14656566.2018.1454430","volume":"19","author":"BW Koes","year":"2018","unstructured":"Koes BW, Backes D, Bindels PJE. Pharmacotherapy for chronic non-specific low back pain: current and future options. Expert Opin Pharmacother. 2018;19(6):537\u201345.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"720_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13075-022-02894-8","volume":"24","author":"P Yu","year":"2022","unstructured":"Yu P, Mao F, Chen J, Ma X, Dai Y, Liu G, et al. Characteristics and mechanisms of resorption in lumbar disc herniation. Arthritis Res Ther. 2022;24(1):205.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"720_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/j.pain.0000000000002725","volume":"164","author":"TZ Guo","year":"2023","unstructured":"Guo TZ, Shi X, Li WW, Wei T, Sahbaie P, Clark JD, et al. Pronociceptive autoantibodies in the spinal cord mediate nociceptive sensitization, loss of function, and spontaneous pain in the lumbar disk puncture model of chronic back pain. Pain. 2023;164(2):421\u201334.","journal-title":"Pain"},{"key":"720_CR8","doi-asserted-by":"publisher","first-page":"104400","DOI":"10.1016\/j.msard.2022.104400","volume":"68","author":"J Peters","year":"2022","unstructured":"Peters J, Longbrake EE. Infection risk in a real-world cohort of patients treated with long-term B-cell depletion for autoimmune neurologic disease. Mult Scler Relat Disord. 2022;68:104400.","journal-title":"Mult Scler Relat Disord"},{"key":"720_CR9","doi-asserted-by":"publisher","first-page":"889286","DOI":"10.3389\/fimmu.2022.889286","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Caterina MJ, Qu L. Sensory neuron expressed FcgammaRI mediates Post-inflammatory arthritis pain in female mice. Front Immunol. 2022;13:889286.","journal-title":"Front Immunol"},{"issue":"766","key":"720_CR10","doi-asserted-by":"publisher","first-page":"eadj1277","DOI":"10.1126\/scitranslmed.adj1277","volume":"16","author":"MJ Lacagnina","year":"2024","unstructured":"Lacagnina MJ, Willcox KF, Boukelmoune N, Bavencoffe A, Sankaranarayanan I, Barratt DT, et al. B cells drive neuropathic pain-related behaviors in mice through IgG-Fc gamma receptor signaling. Sci Transl Med. 2024;16(766):eadj1277.","journal-title":"Sci Transl Med"},{"key":"720_CR11","doi-asserted-by":"crossref","unstructured":"Fiore NT, Willcox KF, Dayani D, Zuberi YA, Heijnen CJ, Grace PM. Reducing IgG accumulation via neonatal Fc receptor (FcRn) Blockade relieves neuropathic pain. Brain Behav Immun. 2025.","DOI":"10.1016\/j.bbi.2025.01.015"},{"key":"720_CR12","doi-asserted-by":"crossref","unstructured":"Guo TZ, Shi X, Li X, Li WW, Wei T, Sahbaie P et al. Autoantibodies cause nociceptive sensitization in a mouse model of degenerative osteoarthritis. Pain. 2024.","DOI":"10.1097\/j.pain.0000000000003500"},{"key":"720_CR13","unstructured":"Hsu Y-M LJ-S, Chang H-C. inventor; AB Biosciences Inc, assignee. Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use. USA. 2022."},{"issue":"10","key":"720_CR14","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.autrev.2019.102366","volume":"18","author":"AW Zuercher","year":"2019","unstructured":"Zuercher AW, Spirig R, Baz Morelli A, Rowe T, Kasermann F. Next-generation Fc receptor-targeting biologics for autoimmune diseases. Autoimmun Rev. 2019;18(10):102366.","journal-title":"Autoimmun Rev"},{"issue":"6317","key":"720_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/350423a0","volume":"350","author":"D Kitamura","year":"1991","unstructured":"Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the Immunoglobulin mu chain gene. Nature. 1991;350(6317):423\u20136.","journal-title":"Nature"},{"issue":"3","key":"720_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0092-8674(94)90115-5","volume":"76","author":"T Takai","year":"1994","unstructured":"Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 1994;76(3):519\u201329.","journal-title":"Cell"},{"issue":"11","key":"720_CR17","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.pain.2014.09.007","volume":"155","author":"WW Li","year":"2014","unstructured":"Li WW, Guo TZ, Shi X, Czirr E, Stan T, Sahbaie P, et al. Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain. 2014;155(11):2377\u201389.","journal-title":"Pain"},{"key":"720_CR18","first-page":"941","volume":"87","author":"LR Poree","year":"1998","unstructured":"Poree LR, Guo TZ, Kingery WS, Maze M. The analgesic potency of Dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors. Anesth Analg. 1998;87:941\u20138.","journal-title":"Anesth Analg"},{"issue":"3","key":"720_CR19","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.4049\/jimmunol.1200138","volume":"189","author":"S Ghosh","year":"2012","unstructured":"Ghosh S, Hoselton SA, Schuh JM. mu-chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J Immunol. 2012;189(3):1322\u20139.","journal-title":"J Immunol"},{"key":"720_CR20","doi-asserted-by":"crossref","unstructured":"Allegri M, Montella S, Salici F, Valente A, Marchesini M, Compagnone C et al. Mechanisms of low back pain: a guide for diagnosis and therapy. F1000Res. 2016;5.","DOI":"10.12688\/f1000research.8105.1"},{"issue":"4","key":"720_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.pmr.2010.07.004","volume":"21","author":"T Maus","year":"2010","unstructured":"Maus T. Imaging the back pain patient. Phys Med Rehabil Clin N Am. 2010;21(4):725\u201366.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"720_CR22","doi-asserted-by":"crossref","unstructured":"Goebel A, Krock E, Gentry C, Israel MR, Jurczak A, Urbina CM et al. Passive transfer of fibromyalgia symptoms from patients to mice. J Clin Invest. 2021;131(13).","DOI":"10.1172\/JCI144201"},{"key":"720_CR23","doi-asserted-by":"publisher","first-page":"174480691879912","DOI":"10.1177\/1744806918799127","volume":"14","author":"J David Clark","year":"2018","unstructured":"David Clark J, Tawfik VL, Tajerian M, Kingery WS. Autoinflammatory and autoimmune contributions to complex regional pain syndrome. Mol Pain. 2018;14:1744806918799127.","journal-title":"Mol Pain"},{"key":"720_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbi.2023.07.001","volume":"113","author":"A Jurczak","year":"2023","unstructured":"Jurczak A, Sandor K, Bersellini Farinotti A, Krock E, Hunt MA, Agalave NM, et al. Insights into FcgammaR involvement in pain-like behavior induced by an RA-derived anti-modified protein autoantibody. Brain Behav Immun. 2023;113:212\u201327.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"720_CR25","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1172\/JCI128010","volume":"129","author":"L Wang","year":"2019","unstructured":"Wang L, Jiang X, Zheng Q, Jeon SM, Chen T, Liu Y, et al. Neuronal FcgammaRI mediates acute and chronic joint pain. J Clin Invest. 2019;129(9):3754\u201369.","journal-title":"J Clin Invest"},{"key":"720_CR26","doi-asserted-by":"crossref","unstructured":"Capossela S, Schlafli P, Bertolo A, Janner T, Stadler BM, Potzel T, et al. Degenerated human intervertebral discs contain autoantibodies against extracellular matrix proteins. Eur Cell Mater. 2014;27:251\u201363. discussion 63.","DOI":"10.22203\/eCM.v027a18"},{"issue":"1","key":"720_CR27","doi-asserted-by":"publisher","first-page":"e1196","DOI":"10.1002\/jsp2.1196","volume":"5","author":"F Ye","year":"2022","unstructured":"Ye F, Lyu FJ, Wang H, Zheng Z. The involvement of immune system in intervertebral disc herniation and degeneration. JOR Spine. 2022;5(1):e1196.","journal-title":"JOR Spine"},{"key":"720_CR28","doi-asserted-by":"crossref","unstructured":"Bhandari V, Bril V. FcRN receptor antagonists in the management of myasthenia Gravis. Front Neurol. 2023;14:1229112.","DOI":"10.3389\/fneur.2023.1229112"},{"key":"720_CR29","doi-asserted-by":"crossref","unstructured":"Bournazos S, Gupta A, Ravetch JV. The role of IgG Fc receptors in antibody-dependent enhancement. Nat Rev Immunol. 2020;20(10):633\u201343.","DOI":"10.1038\/s41577-020-00410-0"},{"key":"720_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fnins.2014.00235","volume":"8","author":"JP Fuller","year":"2014","unstructured":"Fuller JP, Stavenhagen JB, Teeling JL. New roles for Fc receptors in neurodegeneration-the impact on immunotherapy for Alzheimer\u2019s disease. Front Neurosci. 2014;8:235.","journal-title":"Front Neurosci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00720-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00720-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00720-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T13:10:38Z","timestamp":1747055438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00720-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00720-x","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yen-Ming Hsu is the Chief Executive Officer of AB Biosciences. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}